QUEST DIAGNOSTICS INC (DGX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 4B 8B 12B FY07: 6.7B FY08: 7.2B FY09: 7.5B FY10: 7.3B FY11: 7.4B FY12: 7.4B FY13: 7.1B FY14: 7.4B FY15: 7.5B FY16: 7.2B FY17: 7.4B FY18: 7.5B FY19: 7.7B FY20: 9.4B FY21: 10.8B FY22: 9.9B FY23: 9.3B FY24: 9.9B FY25: 11B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 1.5B 3B 4.5B FY09: 3.1B FY10: 3.1B FY11: 3B FY12: 3B FY13: 2.8B FY14: 2.8B FY15: 2.8B FY16: 2.9B FY17: 2.7B FY18: 2.6B FY19: 2.7B FY20: 3.6B FY10 FY12 FY14 FY16 FY18 FY20

Operating Income Annual

0 900M 1.8B 2.7B FY07: 1.1B FY08: 1.2B FY09: 1.4B FY10: 1.3B FY11: 987M FY12: 1.2B FY13: 1.5B FY14: 983M FY15: 1.4B FY16: 1.3B FY17: 1.2B FY18: 1.1B FY19: 1.2B FY20: 2B FY21: 2.4B FY22: 1.4B FY23: 1.3B FY24: 1.3B FY25: 1.6B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

0 700M 1.4B 2.1B FY07: 339.9M FY08: 581.5M FY09: 729.1M FY10: 720.9M FY11: 471M FY12: 556M FY13: 849M FY14: 556M FY15: 709M FY16: 645M FY17: 772M FY18: 736M FY19: 858M FY20: 1.4B FY21: 2B FY22: 946M FY23: 854M FY24: 871M FY25: 992M FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 3B 6B 9B FY07: 4B FY08: 4.3B FY09: 4.3B FY10: 4.3B FY11: 4.4B FY12: 4.4B FY13: 4.3B FY14: 4.6B FY15: 4.7B FY16: 4.6B FY17: 4.7B FY18: 4.9B FY19: 5B FY20: 5.8B FY21: 6.6B FY22: 6.5B FY23: 6.2B FY24: 6.6B FY25: 7.4B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

0 800M 1.6B 2.4B FY07: 926.9M FY08: 1.1B FY09: 997.4M FY10: 1.1B FY11: 895M FY12: 1.2B FY13: 652M FY14: 944M FY15: 821M FY16: 1.1B FY17: 1.2B FY18: 1.2B FY19: 1.2B FY20: 2B FY21: 2.2B FY22: 1.7B FY23: 1.3B FY24: 1.3B FY25: 1.9B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

0 700M 1.4B 2.1B FY07: 707.8M FY08: 850.4M FY09: 830.5M FY10: 912.6M FY11: 734M FY12: 1B FY13: 421M FY14: 636M FY15: 558M FY16: 823M FY17: 923M FY18: 817M FY19: 843M FY20: 1.6B FY21: 1.8B FY22: 1.3B FY23: 864M FY24: 909M FY25: 1.4B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 70M 140M 210M FY08: 196M FY09: 187.8M FY10: 177.3M FY11: 160M FY12: 160M FY13: 153M FY14: 145M FY15: 145M FY16: 142M FY17: 140M FY18: 139M FY19: 136M FY20: 136M FY21: 128M FY22: 118M FY23: 113M FY24: 113M FY25: 113M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 6.00 12.00 18.00 Q4 '08: 2.96 Q1 '10: 3.88 Q2 '10: 3.95 Q3 '10: 4.06 Q4 '10: 4.05 Q1 '11: 2.83 Q2 '11: 2.78 Q3 '11: 2.72 Q4 '11: 2.95 Q1 '12: 4.27 Q2 '12: 4.36 Q3 '12: 4.30 Q4 '12: 3.45 Q1 '13: 3.31 Q2 '13: 3.27 Q3 '13: 4.94 Q4 '13: 5.57 Q1 '14: 5.43 Q2 '14: 5.28 Q3 '14: 3.48 Q4 '14: 3.80 Q1 '15: 3.51 Q2 '15: 3.40 Q3 '15: 4.87 Q4 '15: 4.87 Q1 '16: 5.16 Q2 '16: 5.72 Q3 '16: 4.71 Q4 '16: 4.51 Q1 '17: 4.96 Q2 '17: 4.96 Q3 '17: 4.77 Q4 '17: 5.50 Q1 '18: 5.61 Q2 '18: 5.81 Q3 '18: 6.19 Q4 '18: 5.29 Q1 '19: 5.22 Q2 '19: 5.31 Q3 '19: 5.34 Q4 '19: 6.28 Q1 '20: 5.81 Q2 '20: 5.51 Q3 '20: 8.09 Q4 '20: 10.44 Q1 '21: 13.17 Q2 '21: 16.77 Q3 '21: 16.65 Q4 '21: 15.58 Q1 '22: 15.04 Q2 '22: 12.04 Q3 '22: 10.19 Q4 '22: 7.97 Q1 '23: 6.83 Q2 '23: 6.92 Q3 '23: 6.71 Q4 '23: 7.49 Q1 '24: 7.43 Q2 '24: 7.41 Q3 '24: 7.44 Q4 '24: 7.69 Q1 '25: 7.91 Q2 '25: 8.35 Q3 '25: 8.52 Q4 '25: 8.75 Q1 '26: 9.05 Q2 '26: 9.42 Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.